Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
5 | 158894394 | intron variant | -/TAAA | ins | 0.32 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
1.000 | 0.080 | 5 | 159008453 | intron variant | A/- | del | 0.25 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 5 | 158799646 | intron variant | A/C | snv | 0.85 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
5 | 158840966 | intron variant | A/C | snv | 0.38 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
1.000 | 0.040 | 5 | 158777417 | synonymous variant | A/G | snv | 0.48 | 0.56 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | ||||||
|
1.000 | 0.040 | 5 | 158776504 | intron variant | A/G | snv | 7.9E-02 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.925 | 0.120 | 5 | 158883623 | intron variant | A/G | snv | 0.40 |
|
Mental Disorders | 0.710 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.925 | 0.120 | 5 | 158883623 | intron variant | A/G | snv | 0.40 |
|
Pathological Conditions, Signs and Symptoms; Skin and Connective Tissue Diseases | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.080 | 5 | 158878066 | intron variant | A/G;T | snv |
|
Pathological Conditions, Signs and Symptoms; Skin and Connective Tissue Diseases | 0.700 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
5 | 159095569 | intron variant | C/A;T | snv | 0.50; 1.2E-05 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
0.807 | 0.080 | 5 | 158893869 | intron variant | C/G | snv | 0.32 |
|
Pathological Conditions, Signs and Symptoms; Skin and Connective Tissue Diseases | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.807 | 0.080 | 5 | 158893869 | intron variant | C/G | snv | 0.32 |
|
Pathological Conditions, Signs and Symptoms; Skin and Connective Tissue Diseases | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.807 | 0.080 | 5 | 158893869 | intron variant | C/G | snv | 0.32 |
|
Pathological Conditions, Signs and Symptoms; Skin and Connective Tissue Diseases | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.807 | 0.080 | 5 | 158893869 | intron variant | C/G | snv | 0.32 |
|
0.700 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
0.807 | 0.080 | 5 | 158893869 | intron variant | C/G | snv | 0.32 |
|
Pathological Conditions, Signs and Symptoms; Skin and Connective Tissue Diseases | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.807 | 0.080 | 5 | 158893869 | intron variant | C/G | snv | 0.32 |
|
Pathological Conditions, Signs and Symptoms; Skin and Connective Tissue Diseases | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.807 | 0.080 | 5 | 158893869 | intron variant | C/G | snv | 0.32 |
|
Pathological Conditions, Signs and Symptoms; Skin and Connective Tissue Diseases | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.925 | 0.040 | 5 | 158825430 | intron variant | C/G | snv | 5.3E-02 |
|
0.700 | 1.000 | 1 | 2015 | 2015 | ||||||||
|
0.925 | 0.040 | 5 | 158825430 | intron variant | C/G | snv | 5.3E-02 |
|
0.700 | 1.000 | 1 | 2015 | 2015 | ||||||||
|
0.925 | 0.040 | 5 | 158825430 | intron variant | C/G | snv | 5.3E-02 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 5 | 158806724 | intron variant | C/G | snv | 7.9E-02 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 5 | 158816761 | intron variant | C/G;T | snv |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
1.000 | 0.040 | 5 | 158827432 | intron variant | C/G;T | snv |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
0.851 | 0.080 | 5 | 158817075 | intron variant | C/T | snv | 0.44 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.720 | 1.000 | 5 | 2013 | 2017 | |||||||
|
0.851 | 0.080 | 5 | 158817075 | intron variant | C/T | snv | 0.44 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.720 | 1.000 | 3 | 2013 | 2016 |